Drug recall · September 8, 2021
Clopidogrel Tablets recall
Why: Presence of foreign matter
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15
- Lots / codes
Lot # BCA82021A, Exp 06/2023
- Quantity
- 444,000 tablets / 888 unit packs of 500 count
- Company
- Macleods Pharma Usa Inc, Plainsboro, NJ
- Distribution
- Product was distributed nationwide.
- Initiated
- August 2, 2021 · Voluntary: Firm initiated
- Classified
- August 31, 2021
- Reported
- September 8, 2021
- Ended
- December 2, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clopidogrel
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.